Original news and analysis on international IP policy
Several years ago, the World Intellectual Property Organization set up a project aimed at helping bring together those with intellectual property rights and those with ideas for research to develop medical products for people in need. The project, WIPO Re:Search, has gathered numerous partners and is beginning to look ahead to its next phases, including the possible eventuality of drug development, according to the WIPO secretariat.
The upcoming World Health Organization Executive Board annual January meeting will be 10 days. Included in the list of issues to be addressed are the engagement of the organisation with lobbyists and donors, antimicrobial resistance, and the potential establishment of a pooled fund of voluntary contributions for research and development for diseases primarily affecting developing countries.
The celebration late last year of the 50th anniversary of the Centre de Études Internationales de la Propriété Intellectuelle (CEIPI) at the Université de Strasbourg, France, brought together leading figures in the European IP community. Speakers hailed the origin and successes of the IP system in Europe, and had suggestions for what do better going forward.
The World Health Organization today optimistically announced progress in the search for efficient vaccines to fight the Ebola virus. Tests conducted so far show acceptable safety profiles, and public-private vaccine alliance Gavi has committed to fund Ebola vaccines.
During the recent meeting of the World Intellectual Property Organization copyright committee, a study was presented on exceptions and limitations to copyright for libraries and archives at the national level. The presentation spurred a full day of discussion about how to ensure libraries can continue to provide an indispensable service, and a substantive exchange with the author.
The World Intellectual Property Organization's last committee meeting of the year finished on an amiable note last week. The committee on copyright did not advance on text drafting but, according to the chair and a number of delegations, the weeklong meeting was an opportunity for extensive discussions on substance, the best in a long time.
An informal meeting of World Trade Organization members on a long-discussed register on geographical indications of wines and spirits today showed that member states were committed but not yet inclined to delve into the issues until they have a clearer picture of other sensitive topics of the Doha Round.
The author of a World Intellectual Property Organization-commissioned study said this week that WIPO should take the lead on the issue of limitations and exceptions to copyright for libraries, before the debate and the solution are left to other actors.
World Intellectual Property Organization members have been working in relative secrecy this week to decide how far to apply intellectual property rights protections on broadcasts. To guide them, nongovernmental organisations offered a range of views, from sweeping protections to scaling back the proposed treaty.
After two difficult meetings, the World Intellectual Property Organization copyright committee is meeting this week with the hope of getting closer to a treaty protecting broadcasting organisations, although questions remain on scope and level of protection. The committee is also expected to find ways to work on exceptions and limitations to copyrights for libraries, archives, education and research, as developed countries oppose normative work, and developing countries want international instruments.
An informal meeting is scheduled to take place on 12 December at the World Trade Organization on a multilateral register for geographical indications of wines and spirits. The meeting is expected to discuss how to move the work in the negotiations, and how to reflect it in the post-Bali work programme, according to a source.
A seminar on innovation and access to medicine last week examined the issue of access to hepatitis C treatment, looking at the HIV/AIDS path. Voluntary licences, such as the one entered by Gilead for its hepatitis drugs, have been applauded but such licences often do not cover middle-income countries, which are home to the bulk of hepatitis C patients, and whose poor populations remain unable to access treatment.